Search | Gönül Dağı

Surbhi Verma added blog Botanik
2026-06-18 10:25:40

Breast Cancer Immunotherapy Market: Checkpoint Inhibitors, HER2 Antibodies, and CAR-T Drive Growth to USD 45.3 Billion by 2035
The global Breast Cancer Immunotherapy Market is one of oncology's largest and most dynamically evolving therapeutic markets, growing from USD 23.8 billion in 2025 to USD 45.3 billion by 2035 at a CAGR of 6.6%. As immunotherapy reshapes cancer treatment across all tumor types, breast cancer — the world's most commonly diagnosed cancer — represents the single largest application of...

0 Comments 0 Shares 60 Views 0 Reviews

Please log in to like, share and comment!
Shubham Choudhry added blog Diğer
2026-05-14 14:00:30

HER2 Antibodies Market Segmentation and Forecast: Insights for 2034
The HER2 antibodies industry continues to gain momentum as targeted cancer therapies become increasingly important in modern oncology treatment protocols. Growing prevalence of HER2-positive cancers, especially breast and gastric cancers, has accelerated the adoption of advanced biologic therapies across developed and emerging healthcare systems. Pharmaceutical companies and biotechnology...

0 Comments 0 Shares 89 Views 0 Reviews

Please log in to like, share and comment!
Amit Mohite

added blog Oyun
2026-03-30 16:31:48

Targeted Immunotherapy Transforming the HER2 Antibodies Market Landscape
The global HER2 antibodies market is witnessing consistent growth, driven by the increasing prevalence of HER2-positive cancers and rapid advancements in targeted cancer therapies. Valued at US$ 9.0 billion in 2023, the market is projected to reach US$ 15.7 billion by 2034, expanding at a CAGR of 5.1% during the forecast period. The rising burden of cancers such as breast, ovarian, and gastric...

0 Comments 0 Shares 190 Views 0 Reviews

Please log in to like, share and comment!